Clinical trials
Heart Failure trials in Ireland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
29 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 1 |
| 2014 | 1 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 4 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 15 |
| Terminated | 5 |
| Recruiting | 3 |
| Active, not recruiting | 3 |
| No longer available | 1 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Endotronix, Inc. | 4 |
| Novartis Pharmaceuticals | 3 |
| St Vincent's University Hospital, Ireland | 3 |
| Alere San Diego | 2 |
| Bayer | 2 |
| Boston Scientific Corporation | 2 |
| Medtronic Cardiac Rhythm and Heart Failure | 2 |
| National University of Ireland, Galway, Ireland | 2 |
| ACS Biomarker | 1 |
| AstraZeneca | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Heart Failure | 29 |
| Cardiovascular Diseases | 6 |
| Heart Diseases | 5 |
| Heart Failure, Systolic | 3 |
| Diabetes Mellitus | 2 |
| Hypertension | 2 |
| Myocardial Infarction | 2 |
| Obesity | 2 |
| Ventricular Dysfunction, Left | 2 |
| Breast Neoplasms | 1 |
Trials
Showing 26 to 29 of 29. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.